Role of cellular heparan sulfate proteoglycans in infection of human adenovirus serotype 3 and 35.
about
Adenovirus gene transfer to amelogenesis imperfecta ameloblast-like cellsRequirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor XCell entry and trafficking of human adenovirus bound to blood factor X is determined by the fiber serotype and not hexon:heparan sulfate interactionMacropinocytotic uptake and infection of human epithelial cells with species B2 adenovirus type 35.Glycan microarrays for decoding the glycome.Adenovirus receptors and their implications in gene deliveryMutation of the fiber shaft heparan sulphate binding site of a 5/3 chimeric adenovirus reduces liver tropism.Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14.Identification of amino acid residues important for heparan sulfate proteoglycan interaction within variable region 3 of the feline immunodeficiency virus surface glycoprotein.Diversity of heparan sulfate and HSV entry: basic understanding and treatment strategies.A general strategy for generating intact, full-length IgG antibodies that penetrate into the cytosol of living cells.Symmetry-related clustering of positive charges is a common mechanism for heparan sulfate binding in enteroviruses.Epithelial phenotype confers resistance of ovarian cancer cells to oncolytic adenoviruses.Characterization of human adenovirus serotypes 5, 6, 11, and 35 as anticancer agentsAn adenovirus traffic update: from receptor engagement to the nuclear pore.Adenovirus signalling in entry.Tropism-modification strategies for targeted gene delivery using adenoviral vectors.Development of an AdEasy-based system to produce first- and second-generation adenoviral vectors with tropism for CAR- or CD46-positive cells.Over-expression of human endosulfatase-1 exacerbates cadmium-induced injury to transformed human lung cells in vitro.Transduction of liver metastases after intravenous injection of Ad5/35 or Ad35 vectors with and without factor X-binding protein pretreatmentInfluence of coagulation factor x on in vitro and in vivo gene delivery by adenovirus (Ad) 5, Ad35, and chimeric Ad5/Ad35 vectorsMultimerization of adenovirus serotype 3 fiber knob domains is required for efficient binding of virus to desmoglein 2 and subsequent opening of epithelial junctions.Lysosomal localization and mechanism of membrane penetration influence nonenveloped virus activation of the NLRP3 inflammasome.Oncolytic adenovirus based on serotype 3.Receptor usage of a newly emergent adenovirus type 14.N-terminal α-helix-independent membrane interactions facilitate adenovirus protein VI induction of membrane tubule formation.Expression of human CD46 and trans-complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirus in murine cancer cells.Designer Oncolytic Adenovirus: Coming of Age.
P2860
Q24293503-9CA36F1A-689A-4E0E-A195-B678EA70124DQ28475714-2F430EBB-C19E-4D1F-A455-7965EBC0B49EQ28744246-7560D441-B47D-4CA6-9EBC-FB23100B7560Q30494333-B2483DC8-A857-4EDB-91FA-DF55832CF6FFQ31004845-A77176EC-56A4-434C-B3E1-FEC5A55160C4Q33994011-5E568C4D-21A1-4740-A778-8C8BE43CADF5Q34667746-8BCB1235-E247-450D-A116-81CA09BB6419Q34781681-09C10BB5-3D04-41B3-9673-30DB294D8CC4Q35077801-5602748D-7E95-41CF-9EC9-10EA25547960Q35558287-EAECA502-5755-4EC7-B8B9-8A909BD3A455Q36213205-DBB0903F-03AC-4451-A053-8A607A0EE324Q36276298-330529E7-E9D8-445B-981C-0F10C49D44A3Q37334241-DBB22828-4796-477A-971C-4D7275BF8FE4Q37442235-7EA846FA-F732-451A-A148-A5963757DAC3Q37848821-2769670C-1317-46A6-97C6-9F18D8477C27Q38053484-7F7FC305-F14F-4424-8134-CF3C92E953BDQ38614156-862E6555-E6C6-497E-82FC-B40560BC9810Q39229382-E2E003C8-EE36-49DE-9D05-FC9E97E4571FQ39273931-06C204AB-8A26-46D7-B1D6-0D4027BF7DADQ39278465-73CB7584-E2CF-4145-8EEA-89DBD5F01583Q39502394-7453DC12-2210-4DA1-BA53-50C10BFD7C3BQ39551866-78B9A7A1-0C1E-47F3-B76A-B0012D128A4CQ39593763-DB479199-AB15-4417-95ED-5E86908C5A8EQ39616158-8BC0281F-E146-4276-83EA-A577515E0964Q39869397-F2D811D4-F37C-44CB-AD2F-C01B154F6450Q42716119-DC2DF919-F4E5-4D10-8B8C-EBBA4B794005Q55395331-D90AB877-DD44-44D5-8395-9C9576FE1268Q55467684-C14C698E-3A31-400D-A920-7F1E2AA9654E
P2860
Role of cellular heparan sulfate proteoglycans in infection of human adenovirus serotype 3 and 35.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Role of cellular heparan sulfa ...... adenovirus serotype 3 and 35.
@ast
Role of cellular heparan sulfa ...... adenovirus serotype 3 and 35.
@en
type
label
Role of cellular heparan sulfa ...... adenovirus serotype 3 and 35.
@ast
Role of cellular heparan sulfa ...... adenovirus serotype 3 and 35.
@en
prefLabel
Role of cellular heparan sulfa ...... adenovirus serotype 3 and 35.
@ast
Role of cellular heparan sulfa ...... adenovirus serotype 3 and 35.
@en
P2093
P2860
P1433
P1476
Role of cellular heparan sulfa ...... n adenovirus serotype 3 and 35
@en
P2093
André Lieber
David F Smith
Hongjie Wang
Roma C Yumul
Sebastian Tuve
P2860
P304
P356
10.1371/JOURNAL.PPAT.1000189
P577
2008-10-31T00:00:00Z